News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Robert Jotte presents how Adagrasib shows improvement in PFS and ORR in previously treated patients – Sarah Cannon Research Institute
Photo of Robert Jotte from rockymountaincancercenters.com
Jul 1, 2024, 14:03

Robert Jotte presents how Adagrasib shows improvement in PFS and ORR in previously treated patients – Sarah Cannon Research Institute

Sarah Cannon Research Institute shared on LinkedIn:

“Significant advancements in NSCLC treatment! SCRI’s Dr. Robert Jotte presents how Adagrasib shows improvement in PFS and ORR over Docetaxel in previously treated patients. Watch his detailed discussion on ecancer.”

Source: Sarah Cannon Research Institute/LinkedIn

Adagrasib ASCO24 cancer Cancer research clinical trials docetaxel ecancer immunotherapy NSCLC NSCLC treatment OncoDaily Oncology ORR PFS Robert Jotte Sarah Cannon Research Institute
Special Coverage
Career
Mar 27, 2025, 19:48
Registration is open for AORTIC North America series, Part VII: AORTIC
Blog
Mar 27, 2025, 19:40
Miriam Mutebi: Humbled to host visiting partners AACR to AORTIC-Africa at Aga Khan University Hospital, East Africa
Career
Mar 27, 2025, 19:28
SIOP Young Investigator Award: Present Your Original Research at SIOP Annual Meeting - SIOP
Blog
Mar 27, 2025, 19:23
E. Shyam P. Reddy: Researchers have solved a cellular mystery that may lead to better therapies for colorectal and other types of cancer
Blog
Mar 27, 2025, 19:22
León to Launch Breast Cancer Navigation Program with Experts in June 2025 - City Cancer Challenge
Blog
Mar 27, 2025, 19:17
Mieke Van Hemelrijck: From Brussels to Madrid to Rotterdam – the journey continues
Blog
Mar 27, 2025, 19:15
People, places, and platforms that support a cancer patient’s journey - SPCC
Blog
Mar 27, 2025, 19:06
Peter Leedman: I’m delighted to welcome Professor Joe Trapani AO to the Board of the Harry Perkins Institute of Medical Research
Blog
Mar 27, 2025, 19:05
Zainab Shinkafi-Bagudu: Access to Oncology Medicine aims to close the gap in cancer care in underserved regions
Blog
Mar 27, 2025, 18:58
Barbara Ewals: Why Continuing Medical Education is essential to global health
Blog
Mar 27, 2025, 18:53
The 11th ESO Prostate Cancer Observatory – Thank you to chairs, speakers, and contributors: European School of Oncology
Blog
Mar 27, 2025, 18:52
Ashraf Abdelghany: ELCC 2025 is here